Cargando…
Episensitization: Defying Time’s Arrow
The development of cancer is driven by complex genetic and epigenetic changes that result in aberrant and uncontrolled cellular growth. Epigenetic changes, in particular, are implicated in the silencing or activation of key genes that control cellular growth and apoptosis and contribute to transform...
Autores principales: | Oronsky, Bryan T., Oronsky, Arnold L., Lybeck, Michelle, Oronsky, Neil C., Scicinski, Jan J., Carter, Corey, Day, Regina M., Rodriguez Orengo, Jose F., Rodriguez-Torres, Maribel, Fanger, Gary F., Reid, Tony R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464068/ https://www.ncbi.nlm.nih.gov/pubmed/26125013 http://dx.doi.org/10.3389/fonc.2015.00134 |
Ejemplares similares
-
Episensitization: Therapeutic Tumor Resensitization by Epigenetic Agents: A Review and Reassessment
por: Oronsky, Bryan, et al.
Publicado: (2014) -
Rewriting the Epigenetic Code for Tumor Resensitization: A Review
por: Oronsky, Bryan, et al.
Publicado: (2014) -
Medical Machiavellianism: the tradeoff between benefit and harm with targeted chemotherapy
por: Oronsky, Bryan, et al.
Publicado: (2016) -
Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies
por: Carter, Corey A., et al.
Publicado: (2016) -
No patient left behind: The promise of immune priming with epigenetic agents
por: Carter, Corey A., et al.
Publicado: (2017)